Our new prostate profile combines traditional TPSA and FPSA with a novel combination of serum markers. This innovative approach, helps triage patients into “low-” and “high-risk” categories, allowing general practitioners to improve patient management in primary care and potentially reduce unnecessary, invasive, and costly treatments. Prostate screening usually begins at the age of 40.
